• category:Products
Osheru raises $4.7M to advance blepharoplasty surgical device
Products

Osheru raises $4.7M to advance blepharoplasty surgical device

Funding supports development and commercialization of Ziplyft, a first-of-its-kind, minimally-invasive alternative for eyelid surgery.
Spryte Medical earns FDA Breakthrough Device Designation for nOCT tech
Products

Spryte Medical earns FDA Breakthrough Device Designation for nOCT tech

Company’s neuro OCT platform captures high-resolution, intravascular imaging inside the brain.
FDA clears Oertli's Faros anterior cataract surgery system
Products

FDA clears Oertli's Faros anterior cataract surgery system

Latest surgical system features a compact design and offers rapid operational readiness in under 1 minute.
SUSVIMO phase 3 data supports sustained efficacy for DR, DME
Products

SUSVIMO phase 3 data supports sustained efficacy for DR, DME

FDA has also accepted Genentech’s sBLA for the sustained-release drug delivery system’s diabetic eye disease indications.
FDA clears Heidelberg Engineering's SPECTRALIS OCTA Module with SHIFT technology
Products

FDA clears Heidelberg Engineering's SPECTRALIS OCTA Module with SHIFT technology

Next-gen imaging platform is reported to reduce image acquisition time by 50% at a scan rate of 125 kHz.
Genentech's Vabysmo PFS earns FDA approval for retinal diseases
Products

Genentech's Vabysmo PFS earns FDA approval for retinal diseases

Prefilled Syringe version of the bispecific antibody is indicated for treating wet AMD, DME, and RVO.
Harrow's IHEEZO to be available via Apexus' 340 Prime Vendor Program
Products

Harrow's IHEEZO to be available via Apexus' 340 Prime Vendor Program

New contract through the federal government program also includes access to VIGAMOX and ILEVRO.
Genentech is reintroducing SUSVIMO implant for wet AMD in the US
Products

Genentech is reintroducing SUSVIMO implant for wet AMD in the US

Originally FDA approved in 2021, the ocular implant was voluntarily recalled in 2022.
FDA approves EYLEA biosimilar for serious retinal diseases
Products

FDA approves EYLEA biosimilar for serious retinal diseases

Formycon reports the generic biosimilar demonstrates a comparable efficacy, safety, pharmacokinetics, and immunogenicity to Regeneron’s aflibercept.
J-Code for Glaukos' iDose TR takes effect
Products

J-Code for Glaukos' iDose TR takes effect

Permanent reimbursement code is intended to simplify and ensure consistent coverage for OAG and OHT patients across the U.S. 
Balance Ophthalmics earns De Novo classification for FSYX IOP device
Products

Balance Ophthalmics earns De Novo classification for FSYX IOP device

Compact and portable system is designed to reduce IOP among normal-tension and open-angle glaucoma patients.
Théa introduces new IYUZEH patient resources
Products

Théa introduces new IYUZEH patient resources

New brochure and revamped website target patient-facing information and education—including a simplified process for prescription filling
Zenni Optical now offers contact lens ordering of top brands
Products

Zenni Optical now offers contact lens ordering of top brands

New prescription-based orders feature CooperVision and Bausch + Lomb lenses.
Alcon earns FDA clearance for vitreoretinal and cataract surgery systems
Products

Alcon earns FDA clearance for vitreoretinal and cataract surgery systems

UNITY Vitreoretinal Cataract and Cataract stand-alone systems expand the Alcon Vision Suite of surgical technologies. 
Bausch + Lomb to launch INFUSE for Astigmatism SiHy lenses in the US
Products

Bausch + Lomb to launch INFUSE for Astigmatism SiHy lenses in the US

Latest one-day silicone hydrogel lens addition maintains 96% of moisture for 16 hours.
Nidek introduces the RS-1 Glauvus OCT system
Products

Nidek introduces the RS-1 Glauvus OCT system

Newest ophthalmic diagnostic technology features up to 250 kHz scan speed with deep learning-based analytics for retinal and glaucoma assessments.
Bausch + Lomb launches Blink NutriTears for dry eye
Products

Bausch + Lomb launches Blink NutriTears for dry eye

Newest addition to the Blink product line targets root cause of disease; clinically proven to provide symptom relief in as little as 2 weeks.
BioTissue launches CAM360 AmnioGraft regenerative therapy
Products

BioTissue launches CAM360 AmnioGraft regenerative therapy

New hydrated cryopreserved amniotic membrane features anti-inflammatory, scarring, and angiogenic properties for dry eye and ocular surface conditions.
ZEISS updates CIRRUS 6000 OCT technology
Products

ZEISS updates CIRRUS 6000 OCT technology

Latest features to the CIRRUS platform include the largest data reference base across all OCTs in the United States.
Nordic Pharma launches Lacrifill Canalicular Gel dry eye therapy in the US
Products

Nordic Pharma launches Lacrifill Canalicular Gel dry eye therapy in the US

Novel patented device temporarily blocks tear drainage to maximize tear film preservation in dry eye patients.